Position in JNJ
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$12,370,116
+$1,136,387 QoQ
Shares Held
48,707
+6.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
4.23%
of 13F equity value
Holder Rank
#983
of 4,664 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Costello Asset Management, INC holds $28,771,726 across 14 Drug Manufacturers - General names. JNJ ranks #1 (43.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
48,707 | $12,370,116 | |
| 2 | LLY |
ELI LILLY & Co
|
10,286 | $12,337,338 | |
| 3 | MRK |
Merck & Co., Inc.
|
13,648 | $1,753,768 | |
| 4 | PFE |
Pfizer Inc
|
60,897 | $1,466,399 | |
| 5 | ABBV |
AbbVie Inc.
|
1,269 | $319,331 | |
| 6 | AMGN |
Amgen Inc
|
297 | $107,549 | |
| 7 | NVS |
Novartis AG
|
538 | $84,315 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
525 | $66,328 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,370,116 | 48,707 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $11,233,729 | 45,957 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $9,007,291 | 43,524 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $7,637,449 | 41,190 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $6,045,081 | 39,575 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $6,658,144 | 40,148 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $5,760,648 | 39,833 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $6,578,339 | 40,592 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $6,001,475 | 41,061 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $6,829,853 | 43,175 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $7,062,390 | 45,058 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $7,169,016 | 46,029 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $7,780,764 | 47,008 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $7,322,200 | 47,240 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $8,329,577 | 47,153 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $7,633,322 | 46,727 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $7,813,990 | 44,020 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $7,948,765 | 44,850 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $7,734,587 | 45,213 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $6,452,086 | 39,951 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $6,505,582 | 39,490 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $6,514,834 | 39,640 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $6,204,076 | 39,421 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $5,769,695 | 38,754 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $5,371,925 | 38,199 | Shares | Sole | 2020-07-28 | |
| No filing history on record for this holder in this stock. | ||||||